US FDA declines approval for Novartis’ inclisiran
The drug regulator cited unresolved facility inspection issues for denying approval
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Inclisiran
Novartis analysis shows inclisiran lowers LDL-C with high consistency
The analysis evaluated the efficacy and tolerability of inclisiran on top of a maximally tolerated dose of statins, in two studies…